Chitinase-3-like-1/YKL-40 as marker of circulating tumor cells

Translational Lung Cancer Research

Volumn 4, Issue 3, 2015, Pages 287-291

  Hamilton, Gerhard ^a   Rath, Barbara ^a   Burghuber, Otto ^b  

^a Ludwig Boltzmann Cluster of Translational Oncology   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

Chitinase 3 like 1 (CHI3L1); Chronic obstructive pulmonary disease (COPD); Circulating tumor cells (CTCs); Prognostic marker; Secretome; Small cell lung cancer (SCLC); YKL 40

Indexed keywords

CHITINASE 3 LIKE PROTEIN 1;

CANCER PATIENT; CIRCULATING TUMOR CELL; HUMAN; IN VITRO STUDY; METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHORT SURVEY; UPREGULATION;

EID: 84947025267     PISSN: 22186751     EISSN: 22264477     Source Type: Journal    
DOI: 10.3978/j.issn.2218-6751.2015.04.04     Document Type: Short Survey

References (38)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29
2. Hensing T, Chawla A, Batra R, et al. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol 2014;799:85-117
3. Pietanza MC, Ladanyi M. Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet 2012;44:1074-5
4. Rolfo C, Castiglia M, Hong D, et al. Liquid biopsies in lung cancer: the new ambrosia of researchers. Biochim Biophys Acta 2014;1846:539-46
5. Alix-Panabières C. EPISPOT assay: detection of viable DTCs/CTCs in solid tumor patients. Recent Results Cancer Res 2012;195:69-76
6. Yu M, Bardia A, Aceto N, et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 2014;345:216-20
7. Cayrefourcq L, Mazard T, Joosse S, et al. Establishment and characterization of a cell line from human circulating colon cancer cells. Cancer Res 2015;75:892-901
8. Hodgkinson CL, Morrow CJ, Li Y, et al. Tumorigenicity and genetic profiling of circulating tumor cells in smallcell lung cancer. Nat Med 2014;20:897-903
9. Hamilton G, Burghuber O, Zeillinger R. Circulating tumor cells in small cell lung cancer: ex vivo expansion. Lung 2015;193:451-2
10. Libreros S, Garcia-Areas R, Iragavarapu-Charyulu V. CHI3L1 plays a role in cancer through enhanced production of pro-inflammatory/pro-tumorigenic and angiogenic factors. Immunol Res 2013;57:99-105
11. Shao R, Cao QJ, Arenas RB, et al. Breast cancer expression of YKL-40 correlates with tumour grade, poor differentiation, and other cancer markers. Br J Cancer 2011;105:1203-9
12. Ilie M, Hofman V, Long-Mira E, et al. "Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease. PLoS One 2014;9:e111597
13. Jeet V, Tevz G, Lehman M, et al. Elevated YKL40 is associated with advanced prostate cancer (PCa) and positively regulates invasion and migration of PCa cells. Endocr Relat Cancer 2014;21:723-37
14. Wang XW, Cai CL, Xu JM, et al. Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis. Tumour Biol 2015;36:901-7
15. Zhang JP, Yuan HX, Kong WT, et al. Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma. Tumour Biol 2014;35:12131-7
16. Pan JJ, Ge YS, Xu GL, et al. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma. J Cancer Res Clin Oncol 2013;139:1043-54
17. Kawada M, Seno H, Kanda K, et al. Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 2012;31:3111-23
18. Ku BM, Lee YK, Ryu J, et al. CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells. Int J Cancer 2011;128:1316-26
19. Ngernyuang N, Francescone RA, Jearanaikoon P, et al. Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer. Int J Biochem Cell Biol 2014;51:45-52
20. Ma B, Herzog EL, Lee CG, et al. Role of chitinase 3-like- 1 and semaphorin 7a in pulmonary melanoma metastasis. Cancer Res 2015;75:487-96
21. Høgdall EV, Ringsholt M, Høgdall CK, et al. YKL-40 tissue expression and plasma levels in patients with ovarian cancer. BMC Cancer 2009;9:8
22. Johansen JS, Christensen IJ, Riisbro R, et al. High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 2003;80:15-21
23. Johansen JS, Schultz NA, Jensen BV. Plasma YKL-40: a potential new cancer biomarker? Future Oncol 2009;5:1065-82
24. Johansen JS, Drivsholm L, Price PA, et al. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004;46:333-40
25. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10
26. Francescone RA, Scully S, Faibish M, et al. Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma. J Biol Chem 2011;286:15332-43
27. Scully S, Yan W, Bentley B, et al. Inhibitory activity of YKL-40 in mammary epithelial cell differentiation and polarization induced by lactogenic hormones: a role in mammary tissue involution. PLoS One 2011;6:e25819
28. Singh SK, Bhardwaj R, Wilczynska KM, et al. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL- 40. J Biol Chem 2011;286:39893-903
29. Hormigo A, Gu B, Karimi S, et al. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas. Clin Cancer Res 2006;12:5698-704
30. Kros JM, Mustafa DM, Dekker LJ, et al. Circulating glioma biomarkers. Neuro Oncol 2014. [Epub ahead of print]
31. Faibish M, Francescone R, Bentley B, et al. A YKL-40- neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 2011;10:742-51
32. Formolo CA, Williams R, Gordish-Dressman H, et al. Secretome signature of invasive glioblastoma multiforme. J Proteome Res 2011;10:3149-59
33. Yan C, Ding X, Wu L, et al. Stat3 downstream gene product chitinase 3-like 1 is a potential biomarker of inflammation-induced lung cancer in multiple mouse lung tumor models and humans. PLoS One 2013;8:e61984
34. Schimpl M, Rush CL, Betou M, et al. Human YKL-39 is a pseudo-chitinase with retained chitooligosaccharidebinding properties. Biochem J 2012;446:149-57
35. Lee CG, Dela Cruz CS, Ma B, et al. Chitinase-like proteins in lung injury, repair, and metastasis. Proc Am Thorac Soc 2012;9:57-61
36. Létuvé S, Kozhich A, Arouche N, et al. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 2008;181:5167-73
37. Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med 2014;7:1-11
38. Nam KS, Shon YH. Suppression of metastasis of human breast cancer cells by chitosan oligosaccharides. J Microbiol Biotechnol 2009;19:629-33.